QIP Nominees Pty Ltd v Delinia, Inc

Link copied
Case Copied 16 min read

IP AUSTRALIA

AUSTRALIAN PATENT OFFICE

QIP Nominees Pty Ltd v Delinia, Inc. [2021] APO 24

Patent Application:             2015292889

Title:Molecules that selectively activate regulatory T cells for the treatment of autoimmune diseases

Patent Applicant:                Delinia, Inc.

Opponent:QIP Nominees Pty Ltd

Delegate:Xavier Gisz

Decision Date:  22 June 2021

Hearing Date:  18 June 2021, in Video Conference

Catchwords:  PATENTS - regulation 5.9(2) – extension of time to file evidence in answer – whether there are exceptional circumstances that warrant an extension – extension granted

Representation:

Counsel for the Applicant: Patrick Flynn SC of Eleven Wentworth

IP AUSTRALIA

AUSTRALIAN PATENT OFFICE

Patent Application:             2015292889

Title:Molecules that selectively activate regulatory T cells for the treatment of autoimmune diseases

Patent Applicant:                Delinia, Inc.

Date of Decision:                22 June 2021

DECISION

I allow the extension of time under regulation 5.9(2)(b) for the Applicant to file the Evidence in Answer up to 4 May 2021. The consideration of the stay of the opposition is currently taking place and will be decided separately to this decision.

REASONS FOR DECISION

Background

  1. Patent application 2015292889 (the Application) in the name of Delinia, Inc. (the Applicant) is the national phase entry of PCT/US2015/041177 (with publication number WO 2016/014428) which was filed on 20 July 2015. Examination was requested on 15 June 2018. The Application was accepted on 10 February 2020 and acceptance was advertised on 27 February 2020.

  2. A Notice of Opposition to the grant of the patent was filed on 27 May 2020 by QIP Nominees Pty Ltd (the Opponent). A Statement of Grounds and Particulars was filed on 27 August 2020. Evidence in Support was filed on 27 November 2020, and acknowledged on 4 December 2020. Evidence in Answer was, therefore, due on 4 March 2021.

  3. On 19 February 2021 the Applicant filed a request for an extension of time to file Evidence in Answer. This request was accompanied by declarations of Bernard Nutt, Jay Wilusz, and Basil Krikelis. On 21 February 2021 the Applicant filed a declaration by Lisa Taliadoros.

  4. On 24 February 2021 the Delegate requested more information about the circumstances that led up to the request for an extension of time to file Evidence in Answer.

  5. On 26 February 2021 the Delegate wrote to the Applicant asking whether some of the information in the first Krikelis declaration needed to be kept confidential as was suggested in the declaration itself.

  6. On 4 March 2021 the Applicant filed Evidence in Answer comprising a declaration by Mark Rubenstein with annexures MR-1 to MR-6. The cover letter of the Evidence in Answer stated:

    “These documents complete the Applicant’s Evidence in Answer”.

  7. On 5 March 2021 the Delegate sent a letter to the Applicant stating:

    “We acknowledge a declaration by Mark Rubinstein with Annexures MR-1 to MR-6 on 4 March 2021 which completes the Evidence in Answer.

    Evidence in Reply is now due to be filed by the opponent on or before 5 May 2021.”

  8. On 10 March 2021 the Applicant filed submissions on the extension of time and a second declaration…

CaseChat AU logo

Keep reading for free

Create a free CaseChat account to read QIP Nominees Pty Ltd v Delinia, Inc and more:

  • Read every judgment in full
  • Ask AI and get answers linked to paragraphs
  • See how each paragraph was cited in later cases
  • Download judgments as PDF or Word
Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Details
Case
[2021] APO 24
Decision Date

CaseChat Overview and Summary

QIP Nominees Pty Ltd opposed the grant of patent 2015292889 in the name of Delinia, Inc. The dispute arose from Delinia's patent application for "Molecules that selectively activate regulatory T cells for the treatment of autoimmune diseases." Delinia applied for an extension of time to file its Evidence in Answer, arguing that it had not been aware of the opposition until shortly before the deadline for filing Evidence in Answer. Delinia claimed that emails from its Australian patent attorney were blocked by security measures implemented by its US patent attorney, which led to the delay. The Delegate initially rejected Delinia's application for an extension, but later reconsidered after Delinia provided additional information and declarations.

The legal issues before the Delegate were whether there were exceptional circumstances under regulation 5.9(2)(b) that warranted an extension of time for Delinia to file its Evidence in Answer, and if so, what period of extension would be appropriate. Delinia argued that the blocking of emails by its US patent attorney was a circumstance beyond its control, and that it was unreasonable to expect it to prepare its Evidence in Answer within one month of becoming aware of the opposition. The Delegate had to weigh Delinia's arguments against the strict deadlines in opposition matters, and decide whether an extension was warranted.

The Delegate allowed the extension of time under regulation 5.9(2)(b), finding that the blocking of emails by Delinia's US patent attorney was a circumstance beyond its control. The Delegate accepted that Delinia was unaware of the opposition until two months before the deadline for filing Evidence in Answer, and that it was unreasonable to expect it to prepare its Evidence in Answer within one month. The Delegate also found that a two-month extension was reasonable, given the circumstances. However, the Delegate deferred consideration of a further extension of time until a decision was made on Delinia's request to stay the opposition.

The Delegate granted Delinia a two-month extension of time to file its Evidence in Answer, up until 4 May 2021. The Delegate noted that the stay of the opposition would be decided separately to this decision.

Orders

Orders of the court

Background

Background to the litigation

Evidence

Evidence Before The Court

Decision

Reasons for decision

Ratio Decidendi

Legal Principle Established